Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator
Primary Purpose
Brain Cancer
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
eSNAP
Caregiver Navigator
Sponsored by
About this trial
This is an interventional supportive care trial for Brain Cancer focused on measuring Neuro Oncology
Eligibility Criteria
Inclusion Criteria:
- English-speaking/reading/writing
- Able to complete questionnaires (including by proxy)
- Family Caregivers (FCGs) must self-identify as being a primary FCG of a patient with a primary brain tumor. A primary caregiver is a family member, friend, or other unpaid person who provides at least some care for a patient at home.
- Patients must be diagnosed with new or recurrent primary brain tumor within the last 6 months, receiving at least some evaluation and/or care at Moffitt (i.e. at least one appointment), have a prognosis of at least 6 months
Exclusion Criteria:
- Patients may not participate without a consenting FCG, but FCGs may participate without a consenting patient
- Patients and FCGs who are experiencing acute distress will be excluded from enrollment and referred directly to social work, per Moffitt policy.
Sites / Locations
- Moffitt Cancer CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
eSNAP & Caregiver Navigator
Waitlist Control Condition
Arm Description
eSNAP intervention plus questionnaires
Participants randomly assigned to the waitlist control condition will only complete questionnaires during the 8-week study period. After the 8 weeks, they will then have access to the eSNAP, including completion of questionnaires and 8 weeks of Caregiver Navigator sessions as needed.
Outcomes
Primary Outcome Measures
Family Caregiver Well-Being Using GAD-7 Scale
Caregiver well being will be measured using the Generalized Anxiety Disorder 7 Item Scale (GAD-7). The GAD-7 measures anxiety scoring 0-3 points per item, with a total score range 0-21,with a higher score meaning more anxiety.
Family Caregiver Well-Being using PHQ-8 Scale
Caregiver well being will be measured using the Personal Health Questionnaire Depression 8 Item Scale Scale (PHQ 8). The PHQ 8 measures depression scoring 0-3 points per item, with a total score range of 0-24, with the higher score meaning more depression.
Family Caregiver Well-Being Using Zarit Burden Interview
Caregiver well being will be measured using the Zarit Burden Interview. The Zarit Burden Interview measures burden scoring 0-4 points per item, with a total score range of 0-48, with the higher score meaning more burden.
Neuro Patients Well-Being Using GAD-7 Scale
Neuro patients well being will be measured using the Generalized Anxiety Disorder 7 Item Scale (GAD-7). The GAD-7 measures anxiety scoring 0-3 points per item, with a total score range 0-21,with a higher score meaning more anxiety.
Neuro Patients Well-Being using PHQ-8 Scale
Neuro patients well being will be measured using the Personal Health Questionnaire Depression 8 Item Scale Scale (PHQ 8). The PHQ 8 measures depression scoring 0-3 points per item, with a total score range of 0-24, with the higher score meaning more depression.
Neuro Patients Well-Being using NeuroQol
Neuro patients well being will be measured using Neuro-Qol (Neuro Quality of Life) which will be using T scores where the lower values represent worse outcomes.
Secondary Outcome Measures
Full Information
NCT ID
NCT04268979
First Posted
February 11, 2020
Last Updated
June 16, 2023
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
1. Study Identification
Unique Protocol Identification Number
NCT04268979
Brief Title
Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator
Official Title
Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator Intervention for Neuro-Oncology Couples
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 13, 2020 (Actual)
Primary Completion Date
February 1, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
H. Lee Moffitt Cancer Center and Research Institute
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study is to determine if family caregivers of neuro-oncology patients feel less burdened by utilizing the Electronic Social Network Assessment Program (eSNAP) + the Caregiver Navigator.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Cancer
Keywords
Neuro Oncology
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
225 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
eSNAP & Caregiver Navigator
Arm Type
Experimental
Arm Description
eSNAP intervention plus questionnaires
Arm Title
Waitlist Control Condition
Arm Type
No Intervention
Arm Description
Participants randomly assigned to the waitlist control condition will only complete questionnaires during the 8-week study period. After the 8 weeks, they will then have access to the eSNAP, including completion of questionnaires and 8 weeks of Caregiver Navigator sessions as needed.
Intervention Type
Behavioral
Intervention Name(s)
eSNAP
Other Intervention Name(s)
Electronic Social Network Assessment Program
Intervention Description
eSNAP is a web based tool that quickly collects and organizes social support information entered by Family Caregivers (FCGs) into visualizations of the size, quality, and function of support networks. Visualizations can help FCGs catalogue support resources and present them in a new way, which may make them more salient and remind FCGs of their availability.
Intervention Type
Behavioral
Intervention Name(s)
Caregiver Navigator
Intervention Description
The Caregiver Navigator will have social work training and will help Family Caregivers (FCGs) identify and leverage informal and formal social support, including enrolling or directing FCGs to services.
Primary Outcome Measure Information:
Title
Family Caregiver Well-Being Using GAD-7 Scale
Description
Caregiver well being will be measured using the Generalized Anxiety Disorder 7 Item Scale (GAD-7). The GAD-7 measures anxiety scoring 0-3 points per item, with a total score range 0-21,with a higher score meaning more anxiety.
Time Frame
8 weeks per participant
Title
Family Caregiver Well-Being using PHQ-8 Scale
Description
Caregiver well being will be measured using the Personal Health Questionnaire Depression 8 Item Scale Scale (PHQ 8). The PHQ 8 measures depression scoring 0-3 points per item, with a total score range of 0-24, with the higher score meaning more depression.
Time Frame
8 weeks per participant
Title
Family Caregiver Well-Being Using Zarit Burden Interview
Description
Caregiver well being will be measured using the Zarit Burden Interview. The Zarit Burden Interview measures burden scoring 0-4 points per item, with a total score range of 0-48, with the higher score meaning more burden.
Time Frame
8 weeks per participant
Title
Neuro Patients Well-Being Using GAD-7 Scale
Description
Neuro patients well being will be measured using the Generalized Anxiety Disorder 7 Item Scale (GAD-7). The GAD-7 measures anxiety scoring 0-3 points per item, with a total score range 0-21,with a higher score meaning more anxiety.
Time Frame
8 weeks per participant
Title
Neuro Patients Well-Being using PHQ-8 Scale
Description
Neuro patients well being will be measured using the Personal Health Questionnaire Depression 8 Item Scale Scale (PHQ 8). The PHQ 8 measures depression scoring 0-3 points per item, with a total score range of 0-24, with the higher score meaning more depression.
Time Frame
8 weeks per participant
Title
Neuro Patients Well-Being using NeuroQol
Description
Neuro patients well being will be measured using Neuro-Qol (Neuro Quality of Life) which will be using T scores where the lower values represent worse outcomes.
Time Frame
8 weeks per participant
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
English-speaking/reading/writing
Able to complete questionnaires (including by proxy)
Family Caregivers (FCGs) must self-identify as being a primary FCG of a patient with a primary brain tumor, secondary (metastatic) brain tumor, or leptomeningeal disease diagnosis. A primary caregiver is a family member, friend, or other unpaid person who provides at least some care for a patient at home.
Patients must be diagnosed with new or recurrent primary brain tumor, a secondary (metastatic) brain tumor or leptominingeal disease within the last 9 months, receiving at least some evaluation and/or care at Moffitt (i.e. at least one appointment), have a prognosis of at least 9 months
Exclusion Criteria:
Patients may not participate without a consenting FCG, but FCGs may participate without a consenting patient
Patients and FCGs who are experiencing acute distress will be excluded from enrollment and referred directly to social work, per Moffitt policy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Margaret Byrne, PhD
Phone
813-745-5569
Email
Margaret.Byrne@moffitt.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margaret Byrne, PhD
Organizational Affiliation
Moffitt Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Moffitt Cancer Center
City
Tampa
State/Province
Florida
ZIP/Postal Code
33612
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Margaret Byrne, PhD
Phone
813-745-5569
Email
Margaret.Byrne@moffitt.org
First Name & Middle Initial & Last Name & Degree
Margaret Byrne, PhD
First Name & Middle Initial & Last Name & Degree
Peter Forsyth, MD
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
33865382
Citation
Reblin M, Ketcher D, McCormick R, Barrios-Monroy V, Sutton SK, Zebrack B, Wells KJ, Sahebjam S, Forsyth P, Byrne MM. A randomized wait-list controlled trial of a social support intervention for caregivers of patients with primary malignant brain tumor. BMC Health Serv Res. 2021 Apr 17;21(1):360. doi: 10.1186/s12913-021-06372-w.
Results Reference
derived
Learn more about this trial
Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator
We'll reach out to this number within 24 hrs